Table 1.
Lung Cell Retention | Cell Growth | Stress Response | NK Activity | Lymph Activity | Lymph Apoptosis | Th1/Th2 | NF-κB | TNFα | IL-2 | IL-6 | IL-8 | IFNγ | EGF | HIF-1α | MAPK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intravenous drugs | ||||||||||||||||
Propofol | = | = | + | = | - | - | - | |||||||||
Barbiturates | + | - | + | - | - | - | - | - | - | - | - | |||||
Ketamine | + | - | - | - | ||||||||||||
Volatile agents | ||||||||||||||||
Halothane | - | - | - | |||||||||||||
Isoflurane | - | + | - | + | ||||||||||||
Sevoflurane | - | - | - | + | - | |||||||||||
Desflurane | = | + | ||||||||||||||
Opioids | ||||||||||||||||
Morphine | - | - | - | - | - | - | ||||||||||
Fentanyl | - | - | ||||||||||||||
Alfentanyl | - | - | ||||||||||||||
Sufentanyl | - | - | ||||||||||||||
Local anesthetics | - | - | - |
Notes: Modifications of different actors of the immune system and cancer recurrence are reported separately for each drug used in the perioperative period. =, no modifications; + increased activity; -, reduced activity.
Abbreviations: NK, natural killer; Lymph, lymphocytes; Th1/Th2, ratio between lymphocytes T helper 1 and 2; NF-ΚB, nuclear factor kappa B; TNFα, tumor necrosis factor α; IL, Interleukin; IFNγ, interferon γ; EGF, epidermal growth Factor; HIF-1α, hypoxia inducible factor-1α; MAPK, mitogen-activated protein kinase.